The oral drug Xocova marks the first home-grown medication, developed by Shionogi & Co., which can be prescribed for patients with mild symptoms, suggesting a stable supply of the tablet will be ...

The remaining Xocova tablets produced by Shionogi & Co., Lagevrio capsules made by Merck & Co. and Paxlovid pills manufactured by Pfizer Inc., estimated to be worth 300 billion yen ($1.93 billion ...

Shionogi has prior experience in Covid-19 drug development. In 2024, the company’s antiviral drug Xocova (ensitrelvir) received full approval in Japan, but the Phase III SCORPIO-HR trial ...

Founded in 1878 and based in Osaka, Japan, Shionogi is a drug-discovery-based pharmaceutical company with more than 5,500 employees and operations around the globe, including offices in the US ...

Shionogi Inc., 300 Campus Drive, Florham Park, NJ 07932 USA Antimicrobial resistance (AMR) has become a serious threat to the effective prevention and treatment of infections caused by bacteria ...

Shionogi & Co.'s oral COVID-19 pill in development will likely not be recommended for pregnant women due to abnormalities detected in animal testing, the company said April 12. The Osaka-based ...